Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.
Scipher Medicine has raised $110.0M in total funding. The most recent round was Series D. The last funding was announced in February 2022.
Scipher Medicine's investors include Alumni Ventures, Khosla Ventures, Hitachi Ventures, Neuberger Berman, Optum Ventures.
Scipher Medicine is headquartered in Waltham, United States.
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.
Scipher Medicine is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scipher Medicine — Funding & Investors." VCBacked, February 24, 2022, https://www.vcbacked.co/company/scipher-medicine. Accessed August 14, 2026.
VCBacked. (2022). Scipher Medicine — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/scipher-medicine
{{cite web |title=Scipher Medicine — Funding & Investors |url=https://www.vcbacked.co/company/scipher-medicine |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated